Clinical trial
Relative Effectiveness of Schizophrenia Therapy (REST) Study
NCT01245348 is registered in ClinicalTrials.gov with Medco Health Solutions, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Relative Effectiveness of Schizophrenia Therapy (REST) Study
- Lead sponsor
- Medco Health Solutions, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2010
- Completion date
- December 31, 2012
- Enrollment
- 1,110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.